Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 16;79(2):569-570.
doi: 10.1093/cid/ciad767.

Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL

Tim Crocker-Buque  1 , Nathalie Lachenal  2 , Cindy Narasimooloo  3 , Tleubergen Abdrasuliev  4 , Nargiza Parpieva  5 , Zinaida Tigay  6 , Irina Liverko  5 , Ruzilya Usmanova  5 , Ilhomjon Butabekov  5 , Ronelle Moodliar  3 , Mansa Mbenga  7 , Mohammad Rasool  8 , Bern-Thomas Nyang'wa  9 , Catherine Berry  7
Affiliations

Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL

Tim Crocker-Buque et al. Clin Infect Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. C. B. reports a role as ACTnet board member (research network). N. L. reports that the TB Alliance donated the first batch of pretomanid before its commercialization. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

References

    1. Lotia Farrukh I, Lachenal N, Adenov MM, et al. . Pregnancy and birth outcomes in patients with multidrug-resistant tuberculosis treated with regimens that include new and repurposed drugs. Clin Infect Dis 2024; 78:144–8. - PMC - PubMed
    1. World Health Organization (WHO) . WHO consolidated guidelines on tuberculosis. Module 4: treatment—drug-resistant tuberculosis treatment. Geneva, Switzerland: WHO, 2020. - PubMed
    1. Loveday M, Hughes J, Sunkari B, et al. . Maternal and infant outcomes among pregnant women treated for multidrug/rifampicin-resistant tuberculosis in South Africa. Clin Infect Dis 2021; 72:1158–68. - PMC - PubMed
    1. World Health Organization (WHO) . WHO consolidated guidelines on tuberculosis. Module 4: treatment—drug-resistant tuberculosis treatment, 2022 update. Geneva, Switzerland: WHO, 2022. - PubMed
    1. Stancil SL, Mirzayev F, Abdel-Rahman SM. Profiling pretomanid as a therapeutic option for TB infection: evidence to date. Drug Des Devel Ther 2021; 15:2815–30. - PMC - PubMed

MeSH terms

Substances